“antibiotics” Archives

in
Entry Author Date Location
La Jolla Pharma Steps In With Better Offer, Wins Tetraphase Bidding War 06/24/20 San Diego
Antibiotic Development: HHS Not Yet Sold on “Pull” Incentives 05/16/20 National
Why 2020 Is Pivotal for Microbiome Drug R&D (Or Maybe 2021, Given COVID-19) 04/22/20 National
Forge Inks Roche Deal For Antibiotic Aimed at Drug-Resistant Infections 03/26/20 San Diego
Melinta’s Chapter 11 Auction Draws No Bids, Deerfield to Get Assets 03/04/20 New York
Novo Holdings Repositions Antibiotics Funding Amid “Deteriorated” Market 01/07/20 Europe
Amplyx Inks Novartis Deal for Another Compromised-Immune System Drug 09/17/19 San Diego
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
Ginkgo Eyes Antibiotics With Deal for Warp Drive’s Gene “Mining” Tech 05/15/19 Boston
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More 04/26/19 National
Forge Therapeutics, Basilea Sign Deal to Pursue New Antibiotics 04/24/19 San Diego
Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval 04/15/19 San Francisco
Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections 10/22/18 San Diego
Six Life Science Firms Close Q3 with an IPO, More Are on the Way 09/28/18 Boston
Tetraphase Pharma’s Antibiotic Wins FDA Approval for Gut Infections 08/27/18 Boston
Entasis Therapeutics and Principia Biopharma Join the IPO Queue 08/20/18 Boston
Paratek Eyes FDA Approval of Antibiotic After Advisory Panel Nod 08/08/18 Boston
Achaogen Restructures, Slashes Staff 28% as Antibiotic Launches 07/26/18 San Francisco
Nabriva Bolsters Antibiotics Pipeline with Zavante Acquisition 07/24/18 San Diego
Bio Roundup: Pfizer’s Prices, Novartis Cuts, Gene Therapy Guide & More 07/13/18 National
Summit Therapeutics Ditches Duchenne Drug In Wake of Phase 2 Failure 06/27/18 Boston
Bio Roundup: Not-BIO Party Foul, CRISPR Drama, Sickle Cell Updates 06/15/18 National
Mid-FDA Review, Tetraphase Stumbles Again on Latest Phase 3 Setback 02/14/18 Boston
Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll 11/02/17 Boston
Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists 08/14/17 Boston
Antibiotics Firms Cempra, Melinta Therapeutics Agree to Merger 08/09/17 Raleigh Durham
Tetraphase Claws Back From Failed Study, Eyes FDA Filing With New Data 07/26/17 Boston
Bio Roundup: Obamacare Persists, FDA Approves, Vertex Wows & More 07/21/17 National
SRI’s Michigan Office Will Help Develop New VEE Vaccine 05/15/17 Detroit Ann Arbor
Forge Therapeutics Raises $15M to Take on Drug-Resistant Superbugs 04/25/17 San Diego
Page 1 of 7 next page »